| Date |
Title |
| 2010-10-26 |
Opiorphin, towards a new drug? |
| 2010-10-25 |
Pirfenidone, an antifibrotic drug |
| 2010-10-25 |
Antithrombotic in atrial fibrillation, bleeding risk |
| 2010-10-25 |
Cilostazol in prevention of strokes |
| 2010-10-25 |
Glucosamine, chondroitin, confirmation of their inefficiency |
| 2010-10-25 |
Aspirin, even at low doses, decreases the risk of colorectal cancer |
| 2010-10-25 |
Pegloticase, urate oxidase with sustained effect, authorized in the USA as Krystexxa* |
| 2010-10-25 |
Ivabradine, Procolaran*, in heart failure |
| 2010-10-25 |
Ipilimumab for metastatic melanoma |
| 2010-10-25 |
Zotarolimus, analogue of everolimus, incorpotated in stents. |
| 2010-10-25 |
Fruit and vegetables for the prevention of type 2 diabetes |
| 2010-10-25 |
Boceprevir, telaprevir, protease inhibitors of hepatitis C virus, orally active |
| 2010-10-25 |
Omega-3 fatty acids and cardiovascular protection |
| 2010-10-25 |
Statins in fast food outlets, “MacStatin » |
| 2010-10-25 |
Bisphosphonates and esophageal cancer |
| 2010-10-25 |
FDA for the withdrawal of midodrine |
| 2010-10-25 |
Risk factors for stroke |
| 2010-10-24 |
Polidocanol, Asclera*, to treat small varicose veins |
| 2010-10-24 |
Effects of calcium supplementation on the risk of myocardial infarction. |
| 2010-10-24 |
Alopecia areata, diphenylcyprone and squaric acid dibutylester |
| 2010-10-24 |
Glycopyrronium or glycopyrrolate, a muscarinic receptor antagonist |
| 2010-10-24 |
Lamotrigine, Lamictal*as a possible cause of aseptic meningitis |
| 2010-4-30 |
Interactions between warfarin and antibiotics, especially cotrimoxazole |
| 2010-4-30 |
Statins and hypertension: do they have an antihypertensive effect? |
| 2010-4-30 |
Dutasteride, Avodart * for the prevention of prostate cancer |
| 2010-4-30 |
Fruit and vegetable intake and overall cancer risk |
| 2010-4-30 |
Triclosan and triclocarban |
| 2010-4-30 |
Conflicts of interest and findings of clinical trials: about rosiglitazone |
| 2010-4-2 |
Allopregnanolone and experimental Alzheimer's disease |
| 2010-4-2 |
Nateglinide and valsartan for the prevention of diabetes and cardiovascular events |
| 2010-4-2 |
Fenofibrate |
| 2010-4-2 |
Intensive treatment of arterial hypertension in diabetic patients? |
| 2010-4-2 |
Eprotirome, a thyromimetic lipid-lowering molecule |
| 2010-4-2 |
Variability of blood pressure and risk of stroke |
| 2010-2-15 |
Paroxetine and tamoxifen, pharmacokinetic interaction with clinical consequences |
| 2010-2-15 |
Liposomal amphotericin B in the treatment of the visceral leishmaniasis |
| 2010-2-15 |
Procalcitonin; a help for the prescription of antibiotics |
| 2010-2-15 |
Concomitant prescription of methotrexate and folic acid |
| 2010-2-15 |
Omega-3 fatty acid, telomeres and ageing |
| 2010-2-15 |
Venlafaxine, Effexor*, and the risk of sudden death from cardiac cause |
| 2010-2-15 |
Omega-3 fatty acids, EPA and DHA, and the risk of atrial fibrillation |
| 2010-2-15 |
C-reactive protein, CRP, and extension of the clinical uses of rosuvastatin, Crestor*. |
| 2010-2-15 |
Incidence of atrial fibrillation according to the type of antihypertensive drugs used |
| 2010-1-30 |
Dalfampridine, Ampyra*, to improve walking difficulties in patients with multiple sclerosis |
| 2010-1-30 |
Rupatadine, Wystamm*, H1 antihistamine |
| 2010-1-30 |
Cladribine for multiple sclerosis |
| 2010-1-30 |
Fingolimod for multiple sclerosis |
| 2010-1-30 |
Chlorhexidine-alcohol or povidone-iodine (Bétadine*), like disinfectant in surgery |
| 2010-1-30 |
Antihypertensive drugs, myocardial infarction and stroke |
| 2010-1-30 |
Valproic acid for the treatment of chronic aggressive behaviour of children with attention deficit hyperactivity disorder |
| 2010-1-30 |
Bisphenol A, update from the FDA, January 2010 |
| 2010-1-30 |
Dietary pattern and the risk of depression |
| 2010-1-30 |
Alitretinoin |
| 2010-1-30 |
Inverse agonist |
| 2010-1-24 |
Calcium, vitamin D and fractures |
| 2010-1-24 |
Angiotensin II antagonists, sartans, and the risk of dementia |
| 2010-1-24 |
Mandometer therapy for obesity treatment |
| 2010-1-24 |
Sseasonal flu vaccine, Fluzone High-Dose*, for the elderly, in the USA |
| 2010-1-24 |
Fever as a natural defense mechanism must not be suppressed by acetaminophen |
| 2010-1-24 |
High-frequency electromagnetic field could have a protective effect in an experimental model of Alzheimer disease |
| 2010-1-24 |
Cilengitide, integrin antagonist and antitumor drug under development |
| 2010-1-24 |
Second-generation antipsychotics and metabolic disorders |
| 2010-1-24 |
Effect of antidepressants according to the severity of depression |
| 2010-1-24 |
Ginkgo biloba, memory and cognitive decline |
| 2009-11-10 |
Ofatumumab, Arzerra*, approved in the USA for the treatment of chronic lymphocytic leukemia refractory to fludarabine and alemtuzumab. |
| 2009-11-10 |
Postexposure prophylaxis for HIV infection |
| 2009-11-10 |
Weight gain and increase in cholesterol in children and adolescents treated by second generation antipsychotics. |
| 2009-11-10 |
Consumption of tea and risk of ischemic stroke |
| 2009-11-10 |
Atorvastatine for the prevention of stroke |
| 2009-11-10 |
Stevia rebaudiana, stevioside, sweetener |
| 2009-11-10 |
Omega-3 fatty acids and antidepressants (Sertraline) |
| 2009-11-10 |
The Mediterranean diet against depression and diabetes |
| 2009-11-10 |
Influenza vaccine H1N1, 2 injections in children of 9 years and younger |
 |
|
RSS